Cite
HARVARD Citation
Kienle, D. et al. (n.d.). 1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. European journal of cancer. pp. S194-S195. [Online].